MyFinsight
Home
Blog
About
Editas Medicine, Inc. (EDIT)
Editas Medicine, Inc. (EDIT)
Income Statement
|
Cash Flow
|
Balance Sheet
|
Ratios
Cash Flow Overview
Free Cash flow
-$29,674K
Unit: Thousand (K) dollars
Positive Cash Flow Breakdown
Proceeds from offering of common...
Stock-based compensation expense
Right-of-use assets
Others
Negative Cash Flow Breakdown
Purchases of marketable securiti...
Net loss
Deferred revenue
Others
Subscribe for Financial Insights
Page 1
Quarterly
123
Page 1
Cash Flow
2026-06-30
2026-03-31
2025-12-31
2025-09-30
Net loss
-18,230
-24,982
-5,620
-25,117
Stock-based compensation expense
2,193
2,102
2,129
2,228
Depreciation
416
483
805
721
Loss on disposal of fixed assets
-111
-
0
0
Net accretion of discounts on marketable securities
142
0
0
62
Interest related to sale of future revenues
1,061
1,072
-464
2,399
Impairment of held for sale assets
0
0
34
0
Other non-cash items
128
-111
59
0
Accounts receivable
133
-12,584
7,046
7,542
Prepaid expenses and other current assets
1,871
-248
-887
-593
Right-of-use assets
-1,533
-709
-1,462
-1,428
Other non-current assets
0
0
-14
-1
Accounts payable
-58
1,727
-558
-3,561
Accrued expenses
-4,035
-11,362
-14,912
-543
Accrued interest on sale of future revenues
0
-5,000
0
0
Deferred revenue
-8,194
0
-9,695
0
Operating lease liabilities
-1,637
-805
-1,550
-1,483
Other non-current liabilities
-454
52
-1,814
95
Net cash used in operating activities
-29,568
-23,061
-36,387
-30,843
Purchases of property and equipment
106
92
60
433
Proceeds from the sale of equipment
0
156
118
0
Purchases of marketable securities
29,694
-
0
0
Proceeds from maturities of marketable securities
0
0
0
40,006
Net cash provided by (used in) investing activities
-29,800
64
58
39,573
Proceeds from offering of common stock, net of issuance costs
117,499
0
17,081
17,148
Proceeds from sale of future revenues, net
-
-
0
-
Repayment on sale of future revenues
0
0
0
0
Proceeds from exercise of stock options
36
-
49
21
Proceeds from issuance of common stock under employee stock purchase plan
0
-
196
0
Net cash provided by financing activities
117,535
0
17,326
17,169
Net increase (decrease) in cash, cash equivalents, and restricted cash
58,167
-22,997
-19,003
25,899
Cash, cash equivalents, and restricted cash, beginning of period
126,318
149,315
168,318
135,418
Cash, cash equivalents, and restricted cash, end of period
184,485
-
-
-
Cash and cash equivalents, end of period
181,815
-
-
-
Restricted cash
2,670
-
-
-
Cash, cash equivalents, and restricted cash, end of period
184,485
126,318
149,315
168,318
Restricted cash
2,670
-
-
-
Page 1
Unit: Thousand (K) dollars (except for numbers of shares and EPS). Numbers labeled with * are estimated quarterly values.
Page 1
Buy us a coffee
Time Plot
Show the time plot by selecting a row from the table.
Cash Flow
Proceeds from offering of
common stock, net of...
$117,499K
(1263.26%↑ Y/Y)
Proceeds from exercise of
stock options
$36K
Net cash provided by
financing activities
$117,535K
(1867.11%↑ Y/Y)
Net increase
(decrease) in cash, cash...
$58,167K
(730.84%↑ Y/Y)
Canceled cashflow
$59,368K
Stock-based compensation
expense
$2,193K
(-61.14%↓ Y/Y)
Right-of-use assets
-$1,533K
(82.37%↑ Y/Y)
Interest related to sale
of future revenues
$1,061K
(-74.95%↓ Y/Y)
Depreciation
$416K
(-88.91%↓ Y/Y)
Loss on disposal of
fixed assets
-$111K
(94.94%↑ Y/Y)
Net cash provided by
(used in) investing...
-$29,800K
(-130.09%↓ Y/Y)
Net cash used in
operating activities
-$29,568K
(69.83%↑ Y/Y)
Canceled cashflow
$5,314K
Purchases of marketable
securities
$29,694K
Purchases of property and
equipment
$106K
(-7.02%↓ Y/Y)
Net loss
-$18,230K
(85.90%↑ Y/Y)
Deferred revenue
-$8,194K
(-31.72%↓ Y/Y)
Accrued expenses
-$4,035K
(-277.68%↓ Y/Y)
Prepaid expenses and
other current assets
$1,871K
(347.61%↑ Y/Y)
Operating lease
liabilities
-$1,637K
(81.91%↑ Y/Y)
Other non-current
liabilities
-$454K
(-123.76%↓ Y/Y)
Net accretion of
discounts on marketable...
$142K
(-83.10%↓ Y/Y)
Accounts receivable
$133K
(100.85%↑ Y/Y)
Other non-cash items
$128K
(-67.18%↓ Y/Y)
Accounts payable
-$58K
(-104.71%↓ Y/Y)
Buy us a coffee